Legis Daily

To amend the Public Health Service Act to clarify the intent of the 340B program and provide for enhanced 340B program integrity, and for other purposes.

USA115th CongressHR-6071| House 
| Updated: 6/14/2018
Doris O. Matsui

Doris O. Matsui

Democratic Representative

California

Cosponsors (26)
Elise M. Stefanik (Republican)John Garamendi (Democratic)Richard M. Nolan (Democratic)Adam B. Schiff (Democratic)Joseph P. Kennedy (Democratic)Mark Pocan (Democratic)Brian Higgins (Democratic)Bobby L. Rush (Democratic)Suzan K. DelBene (Democratic)Donald M. Payne (Democratic)Michael E. Capuano (Democratic)Collin C. Peterson (Democratic)Lucille Roybal-Allard (Democratic)Sean Patrick Maloney (Democratic)Stephen F. Lynch (Democratic)Mark DeSaulnier (Democratic)Peter J. Visclosky (Democratic)Eleanor Holmes Norton (Democratic)Jamie Raskin (Democratic)James P. McGovern (Democratic)Nydia M. Velázquez (Democratic)Joseph Crowley (Democratic)Peter Welch (Democratic)Seth Moulton (Democratic)Zoe Lofgren (Democratic)Judy Chu (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Stretching Entity Resources for Vulnerable Communities Act or the SERV Communities Act This bill makes a series of changes to the 340B drug pricing program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers), including alterations relating to program integrity, discrimination against participating entities, and program eligibility.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 12, 2018
Introduced in House
Jun 12, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 14, 2018
Referred to the Subcommittee on Health.
  • June 12, 2018
    Introduced in House


  • June 12, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • June 14, 2018
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 115-4392: To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Administrative law and regulatory proceduresAdministrative remediesCivil actions and liabilityDrug, alcohol, tobacco useFraud offenses and financial crimesGovernment studies and investigationsHealth care costs and insuranceHealth facilities and institutionsHealth information and medical recordsInflation and pricesManufacturingMedical ethicsMedicareMental healthPrescription drugs

To amend the Public Health Service Act to clarify the intent of the 340B program and provide for enhanced 340B program integrity, and for other purposes.

USA115th CongressHR-6071| House 
| Updated: 6/14/2018
Stretching Entity Resources for Vulnerable Communities Act or the SERV Communities Act This bill makes a series of changes to the 340B drug pricing program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers), including alterations relating to program integrity, discrimination against participating entities, and program eligibility.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 12, 2018
Introduced in House
Jun 12, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 14, 2018
Referred to the Subcommittee on Health.
  • June 12, 2018
    Introduced in House


  • June 12, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • June 14, 2018
    Referred to the Subcommittee on Health.
Doris O. Matsui

Doris O. Matsui

Democratic Representative

California

Cosponsors (26)
Elise M. Stefanik (Republican)John Garamendi (Democratic)Richard M. Nolan (Democratic)Adam B. Schiff (Democratic)Joseph P. Kennedy (Democratic)Mark Pocan (Democratic)Brian Higgins (Democratic)Bobby L. Rush (Democratic)Suzan K. DelBene (Democratic)Donald M. Payne (Democratic)Michael E. Capuano (Democratic)Collin C. Peterson (Democratic)Lucille Roybal-Allard (Democratic)Sean Patrick Maloney (Democratic)Stephen F. Lynch (Democratic)Mark DeSaulnier (Democratic)Peter J. Visclosky (Democratic)Eleanor Holmes Norton (Democratic)Jamie Raskin (Democratic)James P. McGovern (Democratic)Nydia M. Velázquez (Democratic)Joseph Crowley (Democratic)Peter Welch (Democratic)Seth Moulton (Democratic)Zoe Lofgren (Democratic)Judy Chu (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 115-4392: To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdministrative remediesCivil actions and liabilityDrug, alcohol, tobacco useFraud offenses and financial crimesGovernment studies and investigationsHealth care costs and insuranceHealth facilities and institutionsHealth information and medical recordsInflation and pricesManufacturingMedical ethicsMedicareMental healthPrescription drugs